Bluth, US
Charles P. Bluth, Glenbrook, NV US
Patent application number | Description | Published |
---|---|---|
20090240115 | COMMUNITY BASED MANAGED HEALTH KIOSK SYSTEM FOR SOLICITING MEDICAL TESTING AND HEALTH STUDY PARTICIPANTS - The present invention is directed to community based managed health kiosk systems for the solicitation of patients for medical testing and health studies, and more particularly to facilitating a kiosk user's access to current and upcoming medical tests and trials that would be appropriate for the given user based upon kiosk health assessments. | 09-24-2009 |
20090240116 | TRIAGE BASED MANAGED HEALTH KIOSK SYSTEM - The present invention is directed to triage based managed health kiosk systems, and more particularly to facilitating a more automated approach to emergency triage situations through use of kiosk systems in combination with on-site health care professionals. The disclosed system allows a user to answer automated health assessment questions, provide health data, and consult with an on-site health care professional, and then receive a health care professional authorized triage assessment of the extent and relative urgency of care needed. | 09-24-2009 |
20090240524 | COMMUNITY BASED MANAGED HEALTH KIOSK AND REMOTE DIAGNOSIS SYSTEM - The present invention is directed to community based managed health kiosk and remote diagnosis systems, and more particularly to facilitating remote diagnosis of kiosk users by remotely located health care professionals through use of kiosk systems in combination with user-data screens that display real-time user health information and real-time user video to the health care professional. The remotely located health care professional is thus able to fully examine and diagnosis a patient without having to ever be on-site or even nearby. | 09-24-2009 |
20090240527 | COMMUNITY BASED MANAGED HEALTH KIOSK SYSTEM - The present invention is directed to community based managed health kiosk systems for recording and analyzing individual user's health-related data in various locations throughout a community. The disclosed kiosk systems collect health data from a user to create and transmit a personal health record and to facilitate communication of the health data to remotely located health care professionals and researchers. | 09-24-2009 |
20090240528 | COMMUNITY BASED MANAGED HEALTH KIOSK AND PRESCRIPTION DISPENSEMENT SYSTEM - The present invention is directed to community based managed health kiosks and prescription drug dispensing systems, and more particularly to facilitating automated drug dispensement by a kiosk system following authorization by a remotely located health care professional monitoring a patient via the kiosk system. | 09-24-2009 |
20090240702 | COMMUNITY BASED MANAGED HEALTH KIOSK AND RESEARCH DATABASE SYSTEM - The present invention is directed to community based health managed health kiosk and research database systems, and more particularly to facilitating large-scale health screening of individuals and aggregation of the resulting data for medical research purposes. The disclosed research database can be combined with community based managed health kiosk systems to allow medical researchers to access searchable, sortable, and non-personally identifiable health information obtained from on-going health screening of kiosk users distributed throughout the world. | 09-24-2009 |
20090241177 | SECURITY SYSTEM FOR A COMMUNITY BASED MANAGED HEALTH KIOSK SYSTEM - The present invention is directed to security systems for community based managed health kiosk systems, and more particularly to protecting the privacy of a user's health information originally obtained at a community-based kiosk system. The disclosed security systems can be combined with community based managed health kiosk systems to enable a patient, or user, to obtain knowledge of his or her health condition/status and to obtain health services from remotely located health care professionals without risk of dissemination of confidential personal health information and records. | 09-24-2009 |
Jon S. Bluth, San Clemente, CA US
Patent application number | Description | Published |
---|---|---|
20140114878 | MOBILE MEETING PROCESSING - A system aggregates data that may be used during the course of a scheduled meeting and allows for the customization of the data for presentation during the scheduled meeting. The system communicates the customized data to meeting participants for discussion and review. The system also accepts inputs during the meeting that define additional meeting information such as bookmarked pages and views that were reviewed during the meeting. The inputs may further define notes reflecting discussions held during the meeting. The system stores information reflecting the bookmarks and notes that were made during the meeting. After the meeting has concluded, the data that was presented during the meeting as well as the bookmarks and notes that were presented during the meeting may be reviewed and selected for inclusion in an electronic document. The document may then be electronically communicated to the participants in the meeting for reference at a later time. | 04-24-2014 |
Martin Bluth, Southfield, MI US
Patent application number | Description | Published |
---|---|---|
20120142621 | Purified Ethyl Ester Sophorolipid for the Treatment of Sepsis - A microbial ethyl esther sophorolipid derivative with no acetylated groups produced by | 06-07-2012 |
Martin H. Bluth, West Hempstead, NY US
Patent application number | Description | Published |
---|---|---|
20080312470 | Mono, Di & Tri Cyclic Compounds Useful for Lowering IgE Concentrations - The present invention is directed to novel compounds which are derivatives of minocycline or doxycycline, pharmaceutical compositions containing same and use thereof in lowering excess IgE levels in a mammal suffering from a disease where IgE is pathogenic. | 12-18-2008 |
20090041781 | METHODS FOR DETECTING PARVOVIRUS INFECTIONS - The present invention provides a method for diagnosing a subject suffering a pathological condition characterized by parvovirus infection by detecting the presence of IgE anti-Parvovirus B 19 antibodies. | 02-12-2009 |
Martin H. Bluth, Detroit, MI US
Patent application number | Description | Published |
---|---|---|
20090186835 | TREATMENT AND PROPHYLAXIS OF CANCER - A method and composition for the prophylaxis or treatment of humans or animals for cancer using a mixture of sophorolipids. | 07-23-2009 |
Martin H. Bluth, Southfield, MI US
Patent application number | Description | Published |
---|---|---|
20100099615 | PANCREATIC REGENERATING PROTEIN I IN CHRONIC PANCREATITIS AND AGING IMPLICATIONS FOR NEW THERAPEUTIC APPROACHES TO DIABETES - The present invention provides a method of treating diabetes, including administering to a mammal diagnosed with diabetes a purified recombinant reg I protein. | 04-22-2010 |
20100158809 | TRUNCATED PAP2 AND METHODS OF MAKING AND USING SAME - A method of treating pancreatitis is provided, including the steps of: providing a mammal having pancreatitis; and administering a therapeutically effective amount of a truncated N-terminal PAP2; and making of an antibody specifically directed to detect PAP2. | 06-24-2010 |
Martin Heath Bluth, Southfield, MI US
Patent application number | Description | Published |
---|---|---|
20110223603 | DIAGNOSING AND MONITORING RESPONSE TO TREATMENT OF NON-INCONTINENT UROLOGICAL AND RELATED DISEASES - Techniques for diagnosing and monitoring response to treatment of non-incontinent urological disorders (NIUD) in a patient are provided. For example, a technique for diagnosing NIUD in a patient includes obtaining peripheral blood-derived nucleic acid containing nucleated acellular components such as serum and/or plasma and/or nucleated cellular components from the patient to provide a reporter function in the patient. Also, a technique for monitoring response to treatment of NIUD in a patient includes obtaining peripheral blood-derived nucleic acid containing nucleated acellular components such as serum and/or plasma and/or nucleated cellular components from the patient to provide a reporter function in the patient. | 09-15-2011 |
20110229882 | DIAGNOSING AND MONITORING RESPONSE TO TREATMENT OF SOLID ORGAN TISSUE DISEASE - Techniques for diagnosing and monitoring response to treatment of a solid organ tissue disease in a patient are provided. For example, a technique for diagnosing a solid organ tissue disease in a patient includes obtaining at least one of one or more blood-derived nucleated acellular components and one or more nucleated cellular components from the patient to provide a reporter function in the patient. Also, a technique for monitoring response to treatment of a solid organ tissue disease in a patient includes obtaining at least one of one or more blood-derived nucleated acellular components and one or more nucleated cellular components from the patient to provide a reporter function in the patient. | 09-22-2011 |
20110311557 | RECIPROCAL SERUM/PLASMA EXCHANGE FOR THE TREATMENT OF CANCER - Techniques for treating cancer are provided. The techniques include obtaining an amount of serum and/or plasma from at least a first patient with a given type of cancer and administering at least a portion of the serum and/or plasma obtained from the first patient to at least a second patient with the same or different type of cancer. Administering the serum and/or plasma obtained from the first patient to the second patient includes administering a therapeutically effective amount of one or more immunoglobulins and one or more soluble receptors corresponding to each immunoglobulin so as to enable reconstitution of a humoral immune system of the second patient to thereby treat the cancer in the second patient. | 12-22-2011 |
Martin Heath Bluth, West Hempstead, NY US
Patent application number | Description | Published |
---|---|---|
20080286790 | Method for Diagnosing Overactive Bladder - Techniques for diagnosing overactive bladder (OAB) in a patient are provided. For example, a technique for diagnosing overactive bladder in a patient includes the step of obtaining peripheral blood mononuclear cells (PBMC) from the patient to provide a reporter function in the patient. | 11-20-2008 |
20100158915 | Method for Diagnosis and Treatment of Pancreatic Cancer - A technique for diagnosing pancreatic cancer includes measuring either level of IgE or cell surface bound cd23 (sCD23) in the patient, comparing the IgE or sCD23 level with that of patient known to have pancreatic cancer and with a level of IgE or sCD23 from a control patient known to not have pancreatic cancer, and identifying the level of IgE or sCD23 in the patient as analogous to either the control patient known to have pancreatic cancer or the control patient known to not have pancreatic cancer A technique for mediating ADCC against pancreatic cancer cells by administering a therapeutically effective amount of IgE to a source containing one or more pancreatic cancer cells. | 06-24-2010 |